C反应蛋白作为HIV感染者肺结核筛查试验的有效性--中国上海,2021-2023年。

IF 4.3 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Lixin Rao, Zheyuan Wu, Jing Chen, Zhen Ning, Xin Shen
{"title":"C反应蛋白作为HIV感染者肺结核筛查试验的有效性--中国上海,2021-2023年。","authors":"Lixin Rao, Zheyuan Wu, Jing Chen, Zhen Ning, Xin Shen","doi":"10.46234/ccdcw2024.190","DOIUrl":null,"url":null,"abstract":"<p><strong>What is already known about this topic?: </strong>The World Health Organization (WHO) has recommended the inclusion of the C-reactive protein (CRP) test in active tuberculosis (ATB) screening algorithms among human immunodeficiency virus (HIV)-infected individuals. The performance of the CRP test in African regions has been well-documented.</p><p><strong>What is added by this report?: </strong>This study analyzed data from a big data platform of Shanghai medical records together with infectious disease surveillance systems. We simulated a screening and plotted a receiver operating characteristic (ROC) curve, which gives the optimal cut-off value of 11.115mg/L with sensitivity and specificity of 0.784 and 0.723, respectively.</p><p><strong>What are the implications for public health practice?: </strong>We obtained a promising perspective on screening for tuberculosis in people living with HIV (PLHIV) using the CRP test in Shanghai. Our study offers an original standpoint for following research.</p>","PeriodicalId":69039,"journal":{"name":"中国疾病预防控制中心周报","volume":null,"pages":null},"PeriodicalIF":4.3000,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11369062/pdf/","citationCount":"0","resultStr":"{\"title\":\"Effectiveness of C-Reactive Protein as a Tuberculosis Screening Test Among HIV-Infected Individuals - Shanghai, China, 2021-2023.\",\"authors\":\"Lixin Rao, Zheyuan Wu, Jing Chen, Zhen Ning, Xin Shen\",\"doi\":\"10.46234/ccdcw2024.190\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>What is already known about this topic?: </strong>The World Health Organization (WHO) has recommended the inclusion of the C-reactive protein (CRP) test in active tuberculosis (ATB) screening algorithms among human immunodeficiency virus (HIV)-infected individuals. The performance of the CRP test in African regions has been well-documented.</p><p><strong>What is added by this report?: </strong>This study analyzed data from a big data platform of Shanghai medical records together with infectious disease surveillance systems. We simulated a screening and plotted a receiver operating characteristic (ROC) curve, which gives the optimal cut-off value of 11.115mg/L with sensitivity and specificity of 0.784 and 0.723, respectively.</p><p><strong>What are the implications for public health practice?: </strong>We obtained a promising perspective on screening for tuberculosis in people living with HIV (PLHIV) using the CRP test in Shanghai. Our study offers an original standpoint for following research.</p>\",\"PeriodicalId\":69039,\"journal\":{\"name\":\"中国疾病预防控制中心周报\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2024-08-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11369062/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中国疾病预防控制中心周报\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.46234/ccdcw2024.190\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国疾病预防控制中心周报","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.46234/ccdcw2024.190","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

摘要

本专题的已知信息:世界卫生组织(WHO)建议将 C 反应蛋白(CRP)检测纳入人体免疫缺陷病毒(HIV)感染者活动性结核病(ATB)筛查算法中。CRP检测在非洲地区的表现已得到充分证明:本研究分析了来自上海医疗记录大数据平台和传染病监测系统的数据。我们模拟了一次筛查,并绘制了接收器操作特征曲线(ROC),得出最佳临界值为 11.115mg/L,灵敏度和特异度分别为 0.784 和 0.723:我们在上海利用 CRP 检测法对艾滋病病毒感染者(PLHIV)进行结核病筛查的前景看好。我们的研究为后续研究提供了一个新的视角。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Effectiveness of C-Reactive Protein as a Tuberculosis Screening Test Among HIV-Infected Individuals - Shanghai, China, 2021-2023.

What is already known about this topic?: The World Health Organization (WHO) has recommended the inclusion of the C-reactive protein (CRP) test in active tuberculosis (ATB) screening algorithms among human immunodeficiency virus (HIV)-infected individuals. The performance of the CRP test in African regions has been well-documented.

What is added by this report?: This study analyzed data from a big data platform of Shanghai medical records together with infectious disease surveillance systems. We simulated a screening and plotted a receiver operating characteristic (ROC) curve, which gives the optimal cut-off value of 11.115mg/L with sensitivity and specificity of 0.784 and 0.723, respectively.

What are the implications for public health practice?: We obtained a promising perspective on screening for tuberculosis in people living with HIV (PLHIV) using the CRP test in Shanghai. Our study offers an original standpoint for following research.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.90
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信